Illicit Injectable Peptides and Regulatory Gaps

JAMA 2026

View at publisher
Authors: Timothy Piatkowski, Kyle T. Ganson, Jason M. Nagata
DOI: 10.1001/jama.2026.10690
Cited by: 5
References: 3

Abstract

This Viewpoint discusses the growing presence of synthetic peptides in enhancement drug use and outlines regulatory gaps created by the blurring of boundaries between medicine and illicit use.

Fields of Study & Subjects

Forensic Toxicology and Drug Analysis Neuroethics Human Enhancement Biomedical Innovations Criminal Law and Policy

Publication details

Journal / source
JAMA
Publisher
American Medical Association (AMA)
Volume
336
Issue
3
Pages
189–189
Publication date
15 June 2026
Language
EN